STERIS plc - Asset Resilience Ratio

Latest as of December 2025: 4.00%

STERIS plc (STE) has an Asset Resilience Ratio of 4.00% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read STE total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

$423.70 Million
Cash + Short-term Investments

Total Assets

$10.59 Billion
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how STERIS plc's Asset Resilience Ratio has changed over time. See STERIS plc shareholders equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down STERIS plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see STERIS plc stock valuation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $423.70 Million 4.0%
Short-term Investments $0.00 0%
Total Liquid Assets $423.70 Million 4.00%

Asset Resilience Insights

  • Limited Liquidity: STERIS plc maintains only 4.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

STERIS plc Industry Peers by Asset Resilience Ratio

Compare STERIS plc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 36.63%
Sinocare Inc
SHE:300298
Medical Devices 3.53%
Shanghai Kinetic Medical Co
SHE:300326
Medical Devices 28.89%
Eurobio Scientific SA
PA:ALERS
Medical Devices 10.52%
EBR Systems Inc
AU:EBR
Medical Devices 48.75%
Aroa Biosurgery Ltd
AU:ARX
Medical Devices 12.13%
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
Medical Devices 19.31%
Affluent Medical SAS
PA:AFME
Medical Devices 0.03%

Annual Asset Resilience Ratio for STERIS plc (2016–2025)

The table below shows the annual Asset Resilience Ratio data for STERIS plc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 1.69% $171.70 Million $10.15 Billion -0.18pp
2024-03-31 1.87% $207.02 Million $11.06 Billion -0.05pp
2023-03-31 1.93% $208.36 Million $10.82 Billion -1.12pp
2022-03-31 3.05% $348.32 Million $11.42 Billion -0.31pp
2021-03-31 3.35% $220.53 Million $6.57 Billion -2.54pp
2020-03-31 5.89% $319.58 Million $5.43 Billion +1.54pp
2019-03-31 4.35% $220.63 Million $5.07 Billion +0.47pp
2018-03-31 3.88% $201.53 Million $5.20 Billion -1.87pp
2017-03-31 5.75% $282.92 Million $4.92 Billion --
2016-03-31 0.00% $0.00 $5.35 Billion --
pp = percentage points

About STERIS plc

NYSE:STE USA Medical Devices
Market Cap
$21.03 Billion
Market Cap Rank
#1235 Global
#492 in USA
Share Price
$214.46
Change (1 day)
+0.70%
52-Week Range
$212.25 - $268.65
All Time High
$268.65
About

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital … Read more